已收盤 02-06 16:00:00 美东时间
+8.520
+4.39%
今日重点评级关注:HC Wainwright & Co.:维持Soleno Therapeutics"买入"评级,目标价从110美元升至120美元;富国银行:维持Soleno Therapeutics"超配"评级,目标价从106美元升至114美元
01-21 11:42
JP Morgan analyst Matthew Boss maintains Five Below (NASDAQ:FIVE) with a Overweight and raises the price target from $210 to $246.
01-20 22:50
今日重点评级关注:Benchmark:维持TNL Mediagene"投机性买入"评级,目标价从3.5美元升至14美元;康托·菲茨杰拉德:维持Eupraxia Pharmaceuticals"超配"评级,目标价从11美元升至19美元
01-16 10:04
今日重点评级关注:HC Wainwright & Co.:维持Rezolve AI"买入"评级,目标价从10美元升至12美元;HC Wainwright & Co.:维持Largo"买入"评级,目标价从2.9美元升至3.1美元
01-15 16:10
今日重点评级关注:HC Wainwright & Co.:维持NioCorp Developments"买入"评级,目标价从9.5美元升至11.25美元;摩根士丹利:维持Chewy"超配"评级,目标价从48美元升至51美元
01-14 11:25
Analysts' ratings for Five Below (NASDAQ:FIVE) over the last quarter vary from ...
01-13 21:01
Jefferies analyst Randal Konik maintains Five Below (NASDAQ:FIVE) with a Buy and lowers the price target from $215 to $210.
01-13 20:56
Top Wall Street analysts changed their outlook on these top names. For a comple...
01-13 20:48
Five Below (NASDAQ:FIVE) raises FY2025 GAAP EPS guidance from $5.51-$5.69 to $6.10-$6.15 vs $5.01 analyst estimate..
01-12 20:30
Five Below (NASDAQ:FIVE) raises Q4 GAAP EPS guidance from $3.34-$3.52 to $3.93-$3.98 vs $2.88 analyst estimate..
01-12 20:29